26
|
Seferian A, Quicke G, Gidaro T, Gargaun E, Gasnier E, Pereon Y, Daron A, Cances C, Vuillerot C, Goemans N, Laugel V, Cuisset J, Schara U, Marquet A, Chabanon A, Annoussamy M, Vissiere D, Servais L. Feasibility of magneto-inertial motion analysis in non-ambulant patients with spinal muscular atrophy. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.065] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
27
|
Chabanon A, Pereon Y, Daron A, Cances C, Vuillerot C, Fontaine S, Goemans N, De Waele L, Laugel V, Cuisset J, Schara U, Gangfuss A, Gidaro T, Gargaun E, Marquet A, Villeret M, Phelep A, Annoussamy M, Servais L. Baseline data from a European prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy – NatHis-SMA. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
28
|
Bharucha-Goebel D, Collins J, Hu Y, Reghan Foley A, Donkervoort S, Leach M, Dastgir N, Vuillerot C, Meilleur K, Jain M, Waite M, Jacobson S, Gordish H, Rutkowski A, Hoffman E, Hathout Y, Bonnemann C. Serum biomarker discovery for congenital muscular dystrophies. Neuromuscul Disord 2016. [DOI: 10.1016/j.nmd.2016.06.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
29
|
Ropars J, Lemeur M, Vuillerot C, Tiffreau V, Peudenier S, Cuisset JM, Pereon Y, Leboeuf F, Delporte L, Delpierre Y, Gross R, Brochard S. Changes in muscle activation during gait of children with duchenne muscular dystrophy. Comput Methods Biomech Biomed Engin 2015; 18 Suppl 1:2042-3. [PMID: 26467719 DOI: 10.1080/10255842.2015.1069615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Nichols C, Lehky T, Waite M, Duong T, Nelson L, Keller K, Lott D, Meilleur K, Collins J, Dastgir J, Vuillerot C, Rutkowski A, Donkervoort S, Leach M, Jain M, Bönnemann C. Electrical impedance myography as a potential biomarker in individuals with COL6-related dystrophy. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
31
|
Schreiber-Bontemps A, Brochard S, Fontaine-Carbonnel S, Chabrier S, Gautheron V, Peudenier S, Rippert P, Rauscent H, Rivier F, Andoni Urtizberea J, Fournier-Mehouas M, Mahé J, Tiffreau V, Lagrue E, Hamroun D, Poirot I, Ragot-Mandry S, Sacconi S, Puy Haubert B, Fafin C, Vuillerot C. Promoting the use of Motor Function Measure (MFM) as outcome measure in patients with Duchenne Muscular Dystrophy (DMD) treated by corticosteroids. Ann Phys Rehabil Med 2015. [DOI: 10.1016/j.rehab.2015.07.331] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
32
|
Olivari C, Roumenoff-Turcant F, Chantran C, Picot M, Berlier P, Mottolese C, Schneider M, Bernard J, Vuillerot C. Childhood craniopharyngioma: What about participation? Ann Phys Rehabil Med 2015. [DOI: 10.1016/j.rehab.2015.07.330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
33
|
Hamo S, Freychet C, Bertholet-Thomas A, Poulat AL, Cochat P, Vuillerot C, Bacchetta J. [Vitamin D supplementation: not too much, not too little!]. Arch Pediatr 2015; 22:868-71. [PMID: 26141804 DOI: 10.1016/j.arcped.2015.04.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2015] [Revised: 02/23/2015] [Accepted: 04/28/2015] [Indexed: 10/23/2022]
Abstract
Vitamin D deficiency is common in the general population and even more frequent in patients with chronic diseases. The prevention of rickets with native vitamin D supplementation is one of the oldest and most effective prophylactic measures ever reported in medicine, leading to an almost complete eradication of vitamin D-deficient rickets in developed countries. We report on two children with vitamin D abnormalities: the first, 10-year-old child developed rickets without any vitamin D supplementation despite different risk factors (autism, ethnicity, nutritional problems, chronic antiepileptic therapies). In contrast, the second, 8-month-old child received double doses of native vitamin D from birth for several months and was referred for acute and symptomatic hypercalcemia. As such, vitamin D supplementation must follow specific rules: neither too much nor too little! We also discuss the emergence of "new" genetic diseases such as mutations in the 24-hydroxylase (CYP24A1) gene inducing neonatal hypercalcemia and nephrocalcinosis: we believe that before prescribing conventional vitamin D supplementation as recommended by the national guidelines, pediatricians should quickly rule out a potential genetic abnormality in phosphate/calcium metabolism (namely a history of lithiasis or hypercalcemia) that would lead to further biological investigations.
Collapse
|
34
|
Vuillerot C, Braillon P, Fontaine-Carbonnel S, Rippert P, Andre E, Iwaz J, Poirot I, Berard C. T.P.44. Neuromuscul Disord 2014. [DOI: 10.1016/j.nmd.2014.06.375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
35
|
Chabrier S, Vuillerot C, Égo A, Debillon T. Infarctus cérébral artériel à révélation néonatale (grande prématurité exclue) : pourquoi des recommandations ? Arch Pediatr 2014; 21:934-7. [DOI: 10.1016/j.arcped.2014.06.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2014] [Accepted: 06/19/2014] [Indexed: 10/25/2022]
|
36
|
Vuillerot C, Rippert P, Kinet V, Renders A, Jain M, Waite M, Glanzman A, Girardot F, Hamroun D, Iwaz J, Quijano-Roy S, Berard C, Poirot I, Bonnemann C. Une Rasch analyse de la mesure de fonction motrice chez les patients atteints de dystrophie musculaire congénitale et myopathie congénitale. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
37
|
Vuillerot C, Braillon P, Fontaine-Carbonnel S, Rippert P, Andre E, Iwaz J, Poirot I, Berard C. Influence of a 2-year steroid treatment on body composition as measured by dual X-ray absorptiometry in boys with Duchenne muscular dystrophy. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
38
|
Darteyre S, Renaud C, Vuillerot C, Presles E, Kossorotoff M, Dinomais M, Lazaro L, Gautheron V, Chabrier S. Quality of life and functional outcome in early school-aged children after neonatal stroke: a prospective cohort study. Eur J Paediatr Neurol 2014; 18:347-53. [PMID: 24503061 DOI: 10.1016/j.ejpn.2014.01.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Revised: 01/09/2014] [Accepted: 01/19/2014] [Indexed: 10/25/2022]
Abstract
BACKGROUND Quality of life (QoL) is recognized internationally as an efficient tool for evaluating health interventions. To our knowledge, QoL has not been specifically assessed in children after neonatal arterial ischemic stroke (AIS). AIM To study the QoL of early school-aged children who suffered from neonatal AIS, and QoL correlation to functional outcome. METHOD We conducted a multicenter prospective cohort study as part of a larger study in full-term newborns with symptomatic AIS. Participating families were sent anonymous QoL questionnaires (QUALIN). Functional outcome was measured using the Wee-FIM scale. Healthy controls in the same age range were recruited in public schools. Their primary caregivers filled in the QUALIN questionnaires anonymously. We used Student's t-test and a rank test to compare patients and controls' QoL and functional outcomes. RESULTS 84 children with neonatal AIS were included. The control group was composed of 74 children, of which ten were later excluded due to chronic conditions. Mean ages and QUALIN median scores did not differ between patients and controls. Median Wee-FIM scores were lower in hemiplegic children than in non-hemiplegic ones (p < 0.001). QoL scores did not seem correlated to functional outcome. INTERPRETATION Those results could support the presence of a "disability paradox" in young children following neonatal AIS.
Collapse
|
39
|
Vuillerot C, Chevignard M, Debillon T, Kossorotoff M, Zerat M, Husson B, Renaud C, Chabrier S. Quelles recommandations autour de la prise en charge MPR des nouveau-nés ayant un pronostic d’hémiplégie après infarctus cérébral néonatal ? Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
40
|
Allard L, Rode G, Luaute J, Jacquin-Courtois S, Rippert P, Hamroun D, Poirot I, Berard C, Vuillerot C. Utilisation de la mesure de fonction motrice pour étudier des limitations d’activités de patients adultes et enfants atteints de la maladie de Charcot-Marie-Tooth. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
41
|
Vuillerot C, Meilleur K, Jain M, Waite M, Wu T, Dastgir J, Donkervoort S, Leach M, Rippert P, Payan C, Iwaz J, Hamroun D, Berard C, Poirot I, Bonnemann C. English cross-cultural translation and validation of the NM-Score: A system for motor function classification in patients with neuromuscular diseases. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
42
|
Vuillerot C, Chevignard M, Debillon T, Kossorotoff M, Zerat M, Husson B, Renaud C, Chabrier S. Perinatal arterial ischemic stroke: Guidelines for diagnosis, management and rehabilitation of newborn with a high risk of hemiplegia. Ann Phys Rehabil Med 2014. [DOI: 10.1016/j.rehab.2014.03.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
43
|
Barnérias C, Quijano S, Mayer M, Estournet B, Cuisset JM, Sukno S, Peudenier S, Laroche C, Chabrier S, Sabouraud P, Vuillerot C, Chabrol B, Halbert C, Cancès C, Beze-Beyrie P, Ledivenah A, Viallard ML, Desguerre I. [Multicentric study of medical care and practices in spinal muscular atrophy type 1 over two 10-year periods]. Arch Pediatr 2014; 21:347-54. [PMID: 24630620 DOI: 10.1016/j.arcped.2014.01.017] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2011] [Revised: 12/25/2013] [Accepted: 01/28/2014] [Indexed: 10/25/2022]
Abstract
AIM Questions about care practices and the role of palliative care in pediatric neurodegenerative diseases have led the Neuromuscular Committee of the French Society of Neurology to conduct a retrospective study in spinal muscular atrophy type 1, a genetic disease most often leading to death before the age of 1 year. MATERIAL AND METHODS A retrospective multicenter study from pediatricians included in the reference centers of pediatric neuromuscular diseases was carried out on two 10-year periods (1989-1998 and 1999-2009). RESULTS The 1989-1998 period included 12 centers with 106 patients, the 1999-2009 period 13 centers with 116 children. The mean age of onset of clinical signs was 2.1 months (range, 0-5.5 months), the median age at diagnosis was 4 months (range, 0-9 months) vs 3 months. The median age of death was 7.5 months (range, 0-24 months) vs 6 months. The care modalities included physiotherapy (90 %), motor support (61 % vs 26 % for the previous period), enteral nutrition by nasogastric tube (52 % vs 24 %), and 3.4 % of children had a gastrostomy (vs 1.8 %). At home, pharyngeal aspiration was used in 64 % (vs 41 %), oxygen therapy in 8 %, noninvasive ventilatory support in 7 %. The mean age at death was 8.1 months (range, 0-24 months) vs 7 months, the time from diagnosis to death was 4 months vs 3 months. Death occurred at home in 23 % vs 17 %, in a pediatric unit in 62 % vs 41 %. The use of analgesics and sedative drugs was reported in 60 % of cases: 40 % morphine (vs 18 %) and benzodiazepines in 48 % (vs 29 %). Respiratory support was limited mostly to oxygen by nasal tube (55 % vs 54 %), noninvasive ventilation in 9 % of the cases, and intubation and assisted mechanical ventilation (2 %). DISCUSSION AND CONCLUSION These results confirm a change in practices and the development of palliative care in children with a French consensus of practices quite different from the standard care in North-America and closer to the thinking of English medical teams. A prospective study within the 2011 national hospital clinical research program (PHRC 2011) is beginning in order to evaluate practices and the role of families and caregivers.
Collapse
|
44
|
Poirot I, Laudy V, Rabilloud M, Roche S, Ginhoux T, Joubrel I, Porsmoguer E, Grimont E, Vuillerot C, Kassaï B. Rehabilitation of 190 non-ambulatory children with cerebral palsy in structures of care or in liberal sector. Ann Phys Rehabil Med 2013; 56:551-60. [PMID: 24120244 DOI: 10.1016/j.rehab.2013.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2013] [Revised: 08/01/2013] [Accepted: 08/05/2013] [Indexed: 11/15/2022]
Abstract
AIMS To describe the rehabilitation of non-ambulatory children with cerebral palsy and to explore adjustability on their individual needs. MATERIAL AND METHOD Data described are extracted from an on-going national cohort study, following during 10years 385 children with cerebral palsy, aged from 4 to 10, Gross Motor Function Classification System IV and V. We analysed data from the first 190 patients (mean age 6years 10months (SD 2.0), 111 boys), focusing on physiotherapy, ergotherapy, psychomotility and speech therapy in medico-social and liberal sectors. RESULTS In medico-social sector, duration of paramedical care is significantly more important than in liberal sector (structure of care: median=4.25h/week, liberal sector: median=2.00h/week) (P<0.0001). More than 4 different types of care per week are given in medico-social sector, while in liberal sector children benefit from only 2 different types of care a week. In investigators opinion, rehabilitation in structures of care is 71.65% adapted as opposed to 18.75% in the liberal sector (P<0.001). Children level V have less time of rehabilitation than the others (P=0.0424). INTERPRETATION Rehabilitation of children with cerebral palsy who are not able to walk, with an objective to improve quality of life, is truly multidisciplinary and suitable in medico-social sector.
Collapse
|
45
|
Chevignard M, Vuillerot C, Kossorotoff M, Zerah M, Husson B, Saliou G, Debillon T, Renaud C, Chabrier S. Presentation of the French National Reference Centre for Pediatric Stroke. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Chevignard M, Vuillerot C, Kossorotoff M, Zerah M, Husson B, Saliou G, Debillon T, Renaud C, Chabrier S. Présentation du Centre national de référence AVC de l’enfant. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
47
|
Poirot I, Laudy V, Rabilloud M, Roche S, Ginhoux T, Mietton C, De Lattre C, Vuillerot C, Kassaï B. Rehabilitation of 190 non-ambulatory children with cerebral palsy in structures of care or in liberal sector. Ann Phys Rehabil Med 2013. [DOI: 10.1016/j.rehab.2013.07.726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Vuillerot C, Rippert P, Berard C, Bonnemann C, Meilleur K, Jain M, Waite M, Payan C, Hamroun D, Poirot I, Ecochard R. P.10.9 A cross sectional validation study of the English version of the NM-Score in patients with neuromuscular diseases. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.539] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
49
|
Vuillerot C, Rippert P, Jain M, Waite M, Glanzman A, Kinet V, Auh S, Berard C, Payan C, Hamroun D, Poirot I, Ecochard R, Bonnemann C. P.10.10 The Rasch-scaled motor function measure for patients with congenital disorders of muscle. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Wagner S, Poirot I, Vuillerot C, Berard C. Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders. Ann Phys Rehabil Med 2011; 54:348-58. [PMID: 21840280 DOI: 10.1016/j.rehab.2011.07.002] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2011] [Revised: 07/01/2011] [Accepted: 07/02/2011] [Indexed: 11/30/2022]
Abstract
UNLABELLED Osteoporosis is a common complication in children with motor impairments. They have a higher risk of fractures (20% during their lifetime) mostly at femoral level. Furthermore, these children have pain yet no clear relation has been established between osteoporosis and pain. The efficacy of bisphosphonates has been validated in adults and for children with osteogenesis imperfecta (OI). However, its use in children with motor impairments has not yet been validated. PATIENTS AND METHODS Retrospective study on the medical charts of children presenting neurological diseases and motor impairments associated to secondary symptomatic osteoporosis. These children underwent treatment with Pamidronate(®) intravenous infusions (I.V.) in Lyon and Valence between 2002 and 2008. Data were collected on pain control, incidence and frequency of fractures and bone mass density (BMD). Data on adverse events were also collected to evaluate treatment's tolerance. RESULTS Twelve children's charts were studied for a total of 50 Pamidronate(®) I.V. infusions. Regarding treatment's efficacy, we observed a clear decrease and even total relief of the pain with improvement reported after 98% of perfusions. Regarding BMD, there was a real improvement after the treatment (e.g., lumbar BMD measures, -46.5% before treatment and -27% after treatment). The adverse events, flu-like syndrome, muscle pain and asymptomatic hypocalcemia, were minor and quickly reversible. CONCLUSION It seems quite essential to screen for osteoporosis-related pain in these children and treat them quickly to avoid a negative impact on their quality of life. Treatment with I.V. bisphosphonates has shown its relevance, yet practical modalities still need to be defined. It would be interesting but quite difficult to implement, in light of the positive effect of this study, a prospective, randomized, controlled, double-blind vs. placebo study on a large enough sample of patients.
Collapse
|